cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.6210413.v1
title: Supplementary data to Gola, Pastewka, Model. Simul. Mater. Sci. Eng. 26, 055006 (2018)

description: * EAM potential datafile for Gola, Pastewka, Model. Simul. Mater. Sci. Eng. 26, 055006 (2018)<br><br>* Results of nested-sampling calculations of Cu-Au phases for the following interatomic embedded-atom method potentials:<br>- Ackland, Vitek, Phys. Rev. B 41, 10324–10333 (1990)- Barrera, de Tendler, Isoardi, Model. Simul. Mater. Sci. Eng. 8 389 (2000) - Foiles, Baskes, Daw, Phys. Rev. B 33 7983–7991(1986) - Gola, Pastewka, Model. Simul. Mater. Sci. Eng., in press (2018)- Zhou, Johnson, Wadley, Phys. Rev. B 69 144113 (2004)
DOI: 10.6084/m9.figshare.14380961.v1
title: Supplementary Material for: Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population

description: <b><i>Background:</i></b> End-stage kidney disease patients on dialysis are particularly susceptible to COVID-19 infection due to comorbidities, age, and logistic constraints of dialysis making social distancing difficult. We describe our experience with hospitalized dialysis patients with COVID-19 and factors associated with mortality. <b><i>Methods:</i></b> From March 1, 2020, to May 31, 2020, all dialysis patients admitted to 4 Emory Hospitals and tested for COVID-19 were identified. Sociodemographic information and clinical and laboratory data were obtained from the medical record. Death was defined as an in-hospital death or transfer to hospice for end-of-life care. Patients were followed until discharge or death. <b><i>Results:</i></b> Sixty-four dialysis patients with COVID-19 were identified. Eighty-four percent were African-American. The median age was 64 years, and 59% were males. Four patients were on peritoneal dialysis, and 60 were on hemodialysis for a median time of 3.8 years, while 31% were obese. Fever (72%), cough (61%), and diarrhea (22%) were the most common symptoms at presentation. Thirty-three percent required admission to intensive care unit, and 23% required mechanical ventilation. The median length of stay was 10 days, while 11 patients (17%) died during hospitalization and 17% were discharged to a temporary rehabilitation facility. Age &gt;65 years (RR 13.7, CI: 1.9–100.7), C-reactive protein &gt;100 mg/dL (RR 8.3, CI: 1.1–60.4), peak D-dimer &gt;3,000 ng/mL (RR 4.3, CI: 1.03–18.2), bilirubin &gt;1 mg/dL (RR 3.9, CI: 1.5–10.4), and history of peripheral vascular disease (RR 3.2, CI: 1.2–9.1) were associated with mortality. Dialysis COVID-19-infected patients were more likely to develop thromboembolic complications than those without COVID-19 (RR 3.7, CI: 1.3–10.1). <b><i>Conclusion:</i></b> In a predominantly African-American population, the mortality of end-stage kidney disease patients admitted with COVID-19 infection was 17%. Age, C-reactive protein, D-dimer, bilirubin, and history of peripheral vascular disease were associated with worse survival.
DOI: 10.6084/m9.figshare.14958822.v1
title: Supplementary Material for: Efficacy and safety of Intravitreal Aflibercept Vs Verteporfin Photodynamic Therapy in a Caucasian Population with Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.

description: Medicine
DOI: 10.6084/m9.figshare.16729228.v1
title: Global Carbon Project per capita fossil CO2 emissions

description: The Global Carbon Project's 2021 release of its fossil CO<sub>2</sub> dataset, here per capita emissions.<br>
DOI: 10.6084/m9.figshare.24249433.v1
title: Luecken Cite-seq human bone marrow 2021 s4d8

description: Dataset published by Luecken et al. 2021 which contains data from human bone marrow measured through joint profiling of single-nucleus RNA and Antibody-Derived Tags (ADTs) using the 10X 3' Single-Cell Gene Expression kit with Feature Barcoding in combination with the BioLegend TotalSeq B Universal Human Panel v1.0.All files stored in this entry are from sample 4 donor 8. Additional sample are available upon request.<b>File description</b><i>filtered_feature_bc_matrix.h5</i>: Filtered feature-barcode matrix containing only detected cell-associated barcodes.<i>raw_feature_bc_matrix.h5</i>: Unfiltered feature-barcode matrix containing every barcode from the list of barcode sequences with at least one read, including background and cell-associated barcodes.<b>Citation</b>Luecken, M. D. <i>et al.</i> A sandbox for prediction and integration of DNA, RNA, and proteins in single cells. Thirty-fifth Conference on Neural Information Processing Systems Datasets and Benchmarks Track (2021).<b>Original data link</b>https://openproblems.bio/neurips_docs/data/dataset/
DOI: 10.6084/m9.figshare.1005016.v1
title: Haq sea level curve

description: Digitisation of the Haq (http://www.sciencemag.org/content/235/4793/1156) sea level curve derived from the data supplied by the supplementary information in Miller et al 2005 (Science 310, 1293 DOI: 10.1126/science.1116412).
DOI: 10.6084/m9.figshare.21671357.v1
title: Site-scale photosynthetic optimum temperature in temperate and subalpine Japanese forests

description: Based on an <em>in situ</em> vegetation survey dataset and satellite-derived Enhanced Vegetation Index (EVI), we identified 1,814 vegetation plots that were characteristic of the EVI of a single dominant species, in temperate and subalpine Japanese forests. For each cell, we pooled EVIs from 2001 to 2020 and estimated the temperature at the time of EVI peak as a species-specific site-scale photosynthetic optimum temperature (T<sub>opt-s</sub>).
DOI: 10.6084/m9.figshare.4205259.v2
title: Supplementary Material for: Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

description: <i>Background:</i> Decision-making for or against neoadjuvant or adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive breast cancer does not follow any clear guidelines, and some patients may unnecessarily undergo chemotherapy and be exposed to the associated toxicity. The aim of this study was to identify the patient population for whom this issue may bear relevance. <i>Methods:</i>Patients being treated with letrozole in the prospective multicenter noninterventional EvAluate-TM study were recruited. The percentage of patients receiving chemotherapy and factors associated with chemotherapy administration were identified. <i>Results:</i> In all, 3,924 (37.4%) patients received chemotherapy before treatment with letrozole. Of these, 293 (20%) underwent neoadjuvant therapy. Younger age was predictive for both adjuvant and neoadjuvant therapy. Overall, decisions in favor of administering chemotherapy are more likely to be made in patients with a higher body mass index (BMI), and neoadjuvant chemotherapy is administered at a higher rate in women with a lower BMI. Concomitant medication influenced the overall decision-making regarding chemotherapy, irrespective of whether it was given on a neoadjuvant or adjuvant basis. <i>Conclusion:</i> There is an ongoing debate as to whether all of the many patients who receive chemotherapy actually benefit from it. Neoadjuvant chemotherapy is frequently administered in this patient population, and this should encourage further research to resolve current clinical and research issues.
DOI: 10.17605/osf.io/tdgqz
title: Effects of visual art observation on technical skills in novice healthcare learners: A scoping review

description: The article is published in F1000Research. (https://doi.org/10.12688/f1000research.129219.2)
DOI: 10.17632/9bzpjyh7ft
title: Artificial Intelligence Empowering Museum Space Layout Design: Insights from China (Training data and images)

description: Artificial Intelligence Empowering Museum Space Layout Design: Insights from China (Training data and images)
DOI: 10.17632/n49gtdz9md
title: A data set on the timing of exam submission

description: A data set on the timing of exam submission
DOI: 10.6084/m9.figshare.17113504.v1
title: Table S3 from Resilience of cold-water coral holobionts to thermal stress

description: List of the most abundant ASVs associated to L. pertusa and M. oculata
DOI: 10.17632/kzw48bf4nv
title: IoT implementation challenges in pharmaceutical supply chains

description: IoT implementation challenges in pharmaceutical supply chains
DOI: 10.6084/m9.figshare.963054.v1
title: Wellcome Trust APC spend 2012-13: data file

description: In an attempt to make the debate around the costs of open access publishing more evidence-based, the Wellcome Trust is releasing into the public domain details of its open access spend in the year 2012-2013, as reported by UK institutions and the Trust’s Major Overseas Programmes in receipt of an OA block grant. The data only include information when an APC was levied. If an author has self-archived a paper, or the publisher provides a gold OA service (but makes no charge), this information is not included in this dataset. Equally, data are not included in cases where a researcher (based at an institution not in receipt of an OA block grant) received a supplement to their grant to cover OA publishing costs
DOI: 10.6084/m9.figshare.9774809.v1
title: Data sets - NAFLD

description: Clinical data related to the publication with PMID:31711876<br>
DOI: 10.6084/m9.figshare.c.3597446_d1.v1
title: MOESM1 of Malaria in pregnancy: a passive surveillance study of pregnant women in low transmission areas of Colombia, Latin America

description: Additional file 1. Parasite genotypes from pregnant women samples.
DOI: 10.17632/nm9dxh99x9
title: Data for: MACHINE LEARNING AND NONLINEAR MODELS FOR THE ESTIMATION OF FUNDAMENTAL PERIOD OF VIBRATION OF MASONRY INFILLED RC FRAME STRUCTURES

description: Accurate estimation of the fundamental period of vibration of masonry infilled RC frame structures using both Machine Learning techniques and concise nonlinear formulas.
DOI: 10.17632/8kfytmbxbc
title: EMG magnitude normalization

description: EMG data were normalized using Max-Min strategy. For comparison across all subjects, ʃIEMG values were normalized through following formula. the result of this equation ranged all the ʃIEMG values in to -1 to +1 ʃIEMGN = ʃIEMGi / ʃIEMGMAX
DOI: 10.6084/m9.figshare.24298093.v2
title: MOIHABFT

description: airplane, boat, butterfly, man, peppers, baboon
DOI: 10.6084/m9.figshare.28191098.v2
title: Suppl. table 1

description: Table S1 summarizes the PCR primers used for SCGN genotype identification and the measurement of GIP and SCGN mRNA. It includes the forward and reverse primer sequences and the corresponding PCR product sizes for each assay.
DOI: 10.6084/m9.figshare.21792785.v1
title: Column Comparison_Apogee_Calibrations

description: Apogee A60 - MESF and size (Rosetta) calibration files and output
DOI: 10.6084/m9.figshare.23211707.v1
title: Supplementary Material for: High renal mast cell density is associated with poor prognosis in patients with IgA Nephropathy

description: Introduction: This observational cohort study evaluated the prognostic value of mast cells in the pathogenesis and progression of IgA nephropathy. Methods: A total of 76 adult IgAN patients were enrolled into this study from Jan 2007 and June 2010. Immunohistochemistry and immunofluorescence were used to identify Tryptase positive mast cells in renal biopsy samples. Patients were classified into Tryptasehigh and Tryptaselow groups. Depending on an average of 96-month follow-up, the predictive value of Tryptase positive mast cells in IgAN progression was analysed. Results: Tryptase positive mast cells were found frequently in IgAN kidneys while rarely observed in normal kidneys. We also found IgAN patients in Tryptasehigh group presented both severe clinical and pathological renal manifestations. Furthermore, Tryptasehigh group contained more interstitial macrophages and lymphocytes infiltration than Tryptaselow group. Higher Tryptase positive cells density is associated with poor prognosis in patients with IgAN. Conclusions: High renal mast cells density is associated with severe renal lesions and poor prognosis in patients with Immunoglobulin A nephropathy. High renal mast cells density might be used as a predictor of poor prognosis in patients with IgAN.
DOI: 10.6084/m9.figshare.8960213.v1
title: Supplementary Material for: Early versus Delayed Fortification of Human Milk in Preterm Infants: A Systematic Review

description: Expressed breast milk (EBM) is commonly supplemented with commercially prepared human milk fortifier to meet the additional nutritional needs of preterm infants. The optimal milk intake at which to introduce fortification is unknown. The objective of this systematic review was to compare the effect of early fortification (EF) versus that of delayed introduction of human milk fortifier (DF) on short-term outcomes including growth, feeding intolerance, length of hospital stay, and maturity at discharge in very-low-birth-weight infants. The search was carried out until March 2019 using 5 electronic databases (PubMed, Ovid Medline, Web of Science, Ovid Embase, and the Cochrane Library). The search was supplemented with a search of the clinical trial registry and reference lists. Eligible studies involved randomized controlled trials that had been designed to compare EF against DF using multi-nutrient fortifier for infants of a birth weight of &lt;1,500 g who were fed exclusively or predominantly EBM. Four authors independently screened the studies for eligibility. A total of 1,972 articles were screened; 2 studies met the inclusion criteria and were included with a total number of participants of 171. The definition of EF and DF was not consistent between the 2 studies. There was no significant impact of EF versus DF on all outcomes. In conclusion, current data are limited and do not provide evidence on the optimal time to start fortification. The definition of EF and DF needs to be agreed upon and further larger randomized controlled trials are required.
DOI: 10.17632/tkkh3styfy
title: Summary of ocular adeno-associated virus (AAV) gene therapy studies

description: Gene therapy using adeno-associated virus (AAV) as a vector represents a novel therapeutic modality to treat ocular diseases by transferring engineered genetic material into target cells for the purpose of preventing, halting or reversing pathological processes.

Despite the enormous advantages of AAV-based gene therapy, there are still concerns about long-term efficacy and safety issues. Given the rising of this groundbreaking approach, we summarized a dataset of ocular AAV gene therapy studies (trials/publications).

Data source: ClinicalTrials.gov, Embase and PubMed.

Search strategy: Strategies are provided in the folder " Extraction process".

Data dictionary: Unifying each variable, a normalized list of data items is provided in the folder " Extraction process".

A trial was eligible for inclusion if the following criteria was met: (1) the study focused on patients with ocular diseases who received rAAV-based gene therapy; for publications, additional criteria were (2) study eyes for treatment are unilateral; (3) there was a clearly disclosed drug information and route of administration (ROA); and (4) the article reported the safety outcomes following gene therapy. If results from one trial were reported in several publications, data included in the ‘Dataset of ocular AAV gene therapy clinical studies.xlsx’ were extracted from the publication that was considered the most appropriate to avoid using duplicate data. If a trial consisted of several phases and was reported separately in the publication, we included the publication from different phases separately. For trial with multiple publications, we list our reason for selection in the folder " Extraction process".

For each study, extracted data included: (1) study characteristics (condition, age, sex, start date, region, phase, status, funder type, study design and enrollment); (2) interventions (study eye, dose, ROA, drug information, and prophylactic immunosuppression regimen); and (3) details of adverse event (AE) and/or a specific safety outcome and/or immune response.
DOI: 10.6084/m9.figshare.13480425.v1
title: 6_type_of_regulator_hg19.zip

description: <b>Genome wide annotation of pig provide </b><b>high resolution of tissue specific regulation, </b><b>deep interpretation </b><b>of domestication and complex traits, further impact of regulatory evolution and human complex traits</b>
DOI: 10.6084/m9.figshare.3530795.v1
title: Supplement 1. WinBUGS 2.2.0 code for the green frog example.

description: File List Supplement.txt Description WinBUGS 2.2.0 code for implementing species occurrence model with multiple states for green frog example. There were 4 levels of occurrence, chorus indices of size 0–3, and the problem has been coded such that the chorus index of 0 corresponds to level 4 in the WinBUGS code, other index values remain unchanged. A non-detection is therefore recorded as a '4' in the data rather than a '0'.
DOI: 10.6084/m9.figshare.9711500.v1
title: Supplementary Material for: Early Predictors for INtubation-SURfactant-Extubation Failure in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Systematic Review

description: The INtubation-SURfactant-Extubation (INSURE) procedure is a widely-used surfactant administration method to treat preterm infants with respiratory distress syndrome (RDS) but is not always successful. We conducted a systematic review to identify early predictive factors for failure of this procedure. A systematic literature search was performed until July 2018 in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials. Original studies comparing INSURE success with INSURE failure in preterm infants with RDS were included. A predefined data extraction form was used to retrieve data from articles, and methodological quality was assessed using the SIGN checklists. Fifteen studies out of 690 identified records met inclusion criteria. Methodological quality varied, only 8 studies performed multivariate analysis. We identified 20 different risk factors in total. Evidence for birth weight (BW) as a predictor for INSURE failure was inconsistent, but there was a significant association between decreasing gestational age (GA) and failure risk. RDS severity was assessed in multiple ways, using arterial blood gas values, imaging, and scoring systems. In conclusion, extremely low BW, low GA, and severe RDS appear to be risk factors for INSURE failure. However, evidence is inconsistent due to important methodological heterogeneity. Therefore, clinical applicability of these results is limited and implies the need for future large cohort studies on this subject.
DOI: 10.6084/m9.figshare.27638127.v1
title: André David Valkenburg - Developing a bioprocess for the production of mannosylerythritol lipids and cellobiose lipids - Chapter 7.xlsx

description: This data corresponds to Chapter 7 of André David Valkenburg's PhD dissertation, titled "Developing a bioprocess for the production of mannosylerythritol lipids and cellobiose lipids".
DOI: 10.17632/xh6jvwsjd3
title: Articles analyzing the concept of nursing care

description: Article extraction matrix for the analysis of the concept of prenatal nursing care
DOI: 10.6084/m9.figshare.13414811.v1
title: Souto Farm Barn 13:13 - Hyperspectral Radiance Image

description: Hyperspectral radiance data. The zipped file contains an unaveraged hyperspectral radiance image in Matlab MAT format, size 1024 × 1344 × 33, and spectral radiance in W m<sup>−2</sup> sr<sup>−1</sup> nm<sup>−1</sup>. The image is one of a pair of images acquired at different times. The zipped file also contains a BMP colour image, rendered from the radiance image, and an information document, which includes geographic location. The separate JPG image of the scene is for illustration only. Padding artefacts may be visible at the image edges. The hyperspectral images were acquired by Sérgio Nascimento, Kinjiro Amano, and David Foster from the Minho region of Portugal in 2002 and 2003.<br>This data item is part of a collection. For details see the data item "README Hyperspectral radiance image pairs 2021" and the published article https://rdcu.be/cd15y.
DOI: 10.6084/m9.figshare.26027092.v3
title: Supplemental Material - Rytz et al. 2024. Association between Serum Estradiol and Cardiovascular Health among Transgender Adults Using Gender-Affirming Estrogen Therapy

description: Supplemental Material eTables 1-6; eFigures 1-3<br><b>For Manuscript: Association between Serum Estradiol and Cardiovascular Health among Transgender Adults Using Gender-Affirming Estrogen Therapy. Rytz et al. 2024</b>
DOI: 10.6084/m9.figshare.7929122.v1
title: gVCF_NA19435

description: 1000 Genomes gVCF mapped to hs37d5 for NA19435. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.17632/fwn8rdfctk
title: Compensatory kinematic movements in various directions after chronic stroke

description: Histogram of kinematic data of reaching task
DOI: 10.17632/xs78ch5jb7
title: Novel bio-polyol synthesis based on date seed oil for low-density rigid polyurethane-polyisocyanurate foams

description: The full dataset used in the study: Novel bio-polyol synthesis based on date seed oil for low-density rigid polyurethane-polyisocyanurate foams
DOI: 10.6084/m9.figshare.13624146.v2
title: Robust Approximate Bayesian Inference With Synthetic Likelihood

description: Bayesian synthetic likelihood (BSL) is now an established method for conducting approximate Bayesian inference in models where, due to the intractability of the likelihood function, exact Bayesian approaches are either infeasible or computationally too demanding. Implicit in the application of BSL is the assumption that the data-generating process (DGP) can produce simulated summary statistics that capture the behaviour of the observed summary statistics. We demonstrate that if this compatibility between the actual and assumed DGP is not satisfied, that is, if the model is misspecified, BSL can yield unreliable parameter inference. To circumvent this issue, we propose a new BSL approach that can detect the presence of model misspecification, and simultaneously deliver useful inferences even under significant model misspecification. Two simulated and two real data examples demonstrate the performance of this new approach to BSL, and document its superior accuracy over standard BSL when the assumed model is misspecified. Supplementary materials for this article are available online.
DOI: 10.17632/fh726r3rzc
title: Data for: A Systems Perspective to Scaling up Food Security Innovations: Lessons from the Canadian International Food Security Research Fund

description: Appendixes of projects
DOI: 10.6084/m9.figshare.16566003.v1
title: Dataset for 'Pre-eradication assessment of feral cat density and population size across Kangaroo Island, South Australia'

description: This data is associated with the paper 'Hohnen, Rosemary, Karleah Berris, Pat Hodgens, Josh Mulvaney, Brenton Florence, Brett P. Murphy, Sarah M. Legge, Chris R. Dickman, and John CZ Woinarski. 2020 "Pre-eradication assessment of feral cat density and population size across Kangaroo Island, South Australia." <i>Wildlife Research</i> 47, no. 8 (2020): 669-676.'<br>This paper assesses feral cat density at nine sites (remote infra-red camera arrays) on Kangaroo Island, South Australia. This dataset only includes data for six of those nine camera arrays as these were the arrays collected by the first author. These arrays are referred to in the paper as Border1, Border 2, Border3, Forest 1, Forest 2, and Farmland 1. In the dataset, there are two spreadsheets of each array 1.) the locations that cameras were deployed (referred to as xx_detector_input), and 2.) a spreadsheet describing the night each individual cat was detected at each camera site (referred to as xx_detections_input). For each array, both the respective spreadsheets are in the format that can be input into the 'secr' package in the program R to calculate density. Further information on the methods used to collect this dataset can be found in the methods section of the respective manuscript.